146 related articles for article (PubMed ID: 32047552)
61. Cdk6-cyclin D3 activity in murine ES cells is resistant to inhibition by p16(INK4a).
Faast R; White J; Cartwright P; Crocker L; Sarcevic B; Dalton S
Oncogene; 2004 Jan; 23(2):491-502. PubMed ID: 14724578
[TBL] [Abstract][Full Text] [Related]
62. PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity.
Logan JE; Mostofizadeh N; Desai AJ; VON Euw E; Conklin D; Konkankit V; Hamidi H; Eckardt M; Anderson L; Chen HW; Ginther C; Taschereau E; Bui PH; Christensen JG; Belldegrun AS; Slamon DJ; Kabbinavar FF
Anticancer Res; 2013 Aug; 33(8):2997-3004. PubMed ID: 23898052
[TBL] [Abstract][Full Text] [Related]
63. miR-145 downregulates the expression of cyclin-dependent kinase 6 in human cervical carcinoma cells.
Zhang J; Wang L; Li B; Huo M; Mu M; Liu J; Han J
Exp Ther Med; 2014 Aug; 8(2):591-594. PubMed ID: 25009625
[TBL] [Abstract][Full Text] [Related]
64. CSN6 promotes tumorigenesis of gastric cancer by ubiquitin-independent proteasomal degradation of p16
Du W; Liu Z; Zhu W; Li T; Zhu Z; Wei L; Song J; Pei D
Cancer Biol Med; 2019 Aug; 16(3):514-529. PubMed ID: 31565481
[TBL] [Abstract][Full Text] [Related]
65. MSK2 promotes proliferation and tumor formation in squamous cervical cancer via PAX8/RB-E2F1/cyclin A2 axis.
Wu Y; Li H; Wang H; Zhang F; Cao H; Xu S
J Cell Biochem; 2019 Jul; 120(7):11432-11440. PubMed ID: 30756420
[TBL] [Abstract][Full Text] [Related]
66. Apigenin 7-glucoside impedes hypoxia-induced malignant phenotypes of cervical cancer cells in a p16-dependent manner.
Li Y; Man X; Zhang Q; Wang X; Yang Y
Open Life Sci; 2024; 19(1):20220819. PubMed ID: 38585640
[TBL] [Abstract][Full Text] [Related]
67. Autophagy regulates the localization and degradation of p16
Coryell PR; Goraya SK; Griffin KA; Redick MA; Sisk SR; Purvis JE
Aging Cell; 2020 Jul; 19(7):e13171. PubMed ID: 32662244
[TBL] [Abstract][Full Text] [Related]
68. Role of the p16 tumor suppressor gene in cancer.
Liggett WH; Sidransky D
J Clin Oncol; 1998 Mar; 16(3):1197-206. PubMed ID: 9508208
[TBL] [Abstract][Full Text] [Related]
69. Association between serum P16ink4A concentration and CIN and cervical cancer among women attending a cervical cancer clinic in western Uganda: A case control study.
Ssedyabane F; Ngonzi J; Tusubira D; Nambi Najjuma J; Kajabwangu R; Okeny C; Nuwashaba D; Namuli A; Niyonzima N
Gynecol Oncol Rep; 2024 Jun; 53():101388. PubMed ID: 38590932
[TBL] [Abstract][Full Text] [Related]
70. Metabolic Interplay in the Tumor Microenvironment: Implications for Immune Function and Anticancer Response.
Youssef R; Maniar R; Khan J; Mesa H
Curr Issues Mol Biol; 2023 Dec; 45(12):9753-9767. PubMed ID: 38132455
[TBL] [Abstract][Full Text] [Related]
71. A pyroptosis gene-based prognostic model for predicting survival in low-grade glioma.
Wang H; Yan L; Liu L; Lu X; Chen Y; Zhang Q; Chen M; Cai L; Dai Z
PeerJ; 2023; 11():e16412. PubMed ID: 38025749
[TBL] [Abstract][Full Text] [Related]
72. Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions.
Ye J; Zheng L; He Y; Qi X
MedComm (2020); 2023 Oct; 4(5):e368. PubMed ID: 37719443
[TBL] [Abstract][Full Text] [Related]
73. Role of the RNA-binding protein family in gynecologic cancers.
Hao L; Zhang J; Liu Z; Zhang Z; Mao T; Guo J
Am J Cancer Res; 2023; 13(8):3799-3821. PubMed ID: 37693158
[TBL] [Abstract][Full Text] [Related]
74. Expression of Progesterone Receptor A as an Independent Negative Prognosticator for Cervical Cancer.
Garrido F; Wild CM; Jeschke U; Dannecker C; Mayr D; Cavailles V; Mahner S; Kost B; Heidegger HH; Vattai A
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769131
[TBL] [Abstract][Full Text] [Related]
75. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
Sun K; Huang C; Li JZ; Luo ZX
World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
[TBL] [Abstract][Full Text] [Related]
76. A Comparative Study on the Accuracy and Efficacy Between Dalton and CINtec
Li Y; Fu Y; Cheng B; Xie X; Wang X
Front Oncol; 2021; 11():815213. PubMed ID: 35141154
[TBL] [Abstract][Full Text] [Related]
77. Bioinformatics Analyses Indicate That Cathepsin G (CTSG) is a Potential Immune-Related Biomarker in Oral Squamous Cell Carcinoma (OSCC).
Huang GZ; Wu QQ; Zheng ZN; Shao TR; Li F; Lu XY; Ye HY; Chen GX; Song YX; Zeng WS; Ai YL; Lv XZ
Onco Targets Ther; 2021; 14():1275-1289. PubMed ID: 33658795
[TBL] [Abstract][Full Text] [Related]
78. p16 promotes proliferation in cervical carcinoma cells through CDK6-HuR-IL1A axis.
Li M; Yang J; Liu K; Yang J; Zhan X; Wang L; Shen X; Chen J; Mao Z
J Cancer; 2020; 11(6):1457-1467. PubMed ID: 32047552
[TBL] [Abstract][Full Text] [Related]
79. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
[TBL] [Abstract][Full Text] [Related]
80. Downregulation of p16(ink4a) inhibits cell proliferation and induces G1 cell cycle arrest in cervical cancer cells.
Zhang CY; Bao W; Wang LH
Int J Mol Med; 2014 Jun; 33(6):1577-85. PubMed ID: 24714974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
